Diseases · Entity Annotation Prototype (beta)

3articles mentioning diseases

7disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: PROC ×

PROC

This disease is selected. Its supporting articles are shown below.

PROC3

Articles mentioning PROC

3 articles · page 1 of 1

500 Biomarker identification of early response and resistance to combinatorial anti-angiogenic and immune-checkpoint blockade therapy in the recurrent ovarian cancer setting

jitc · abstract · 2025-11-04 · 3 matching annotations

93.2%

High-grade serous ovarian cancer PROC platinum-resistant ovarian cancer HGSOC atezolizumab bevacizumab atezolizumab-containing aspirin EORTC-1508GCG low-dose aspirin+1 more

…Background High-grade serous ovarian cancer (HGSOC) is the deadliest gynecological malignancy, with limited…

547 A phase 1b study of intraperitoneal cytokine-induced memory-like (CIML) natural killer (NK) cell therapy in platinum resistant ovarian cancer

jitc · abstract · 2025-11-04 · 3 matching annotations

89.5%

myeloid leukemia PROC Platinum resistant ovarian cancer platinum-resistant ovarian cancer ovarian cancer ECOG Performance Status Dana-Farber Cancer Institute PHASE ONE Foundation IL-12 IL-15+6 more

…ry-like natural killer cells exhibit enhanced responses against myeloid leukemia. Sci Transl Med. Sep 21 2016;8(357):357ra123. doi:10.1126/scitr…

New frontiers in the management of recurrent epithelial ovarian cancer: a comprehensive review

gocm · abstract · 2025-12-14 · 1 matching annotations

80.3%

ovarian cancer HER2-expressing disease PROC Bevacizumab Trastuzumab deruxtecan adavosertib mirvetuximab soravtansine platinum-based therapy hyperthermic intraperitoneal chemotherapy

…o demonstrate benefit in phase III trials.In platinum-resistant ovarian cancer (PROC), platinum rechallenge retains activity in selected patie…